GB201617723D0 - Method for predicting prostate cancer metastasis - Google Patents
Method for predicting prostate cancer metastasisInfo
- Publication number
- GB201617723D0 GB201617723D0 GBGB1617723.0A GB201617723A GB201617723D0 GB 201617723 D0 GB201617723 D0 GB 201617723D0 GB 201617723 A GB201617723 A GB 201617723A GB 201617723 D0 GB201617723 D0 GB 201617723D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prostate cancer
- cancer metastasis
- predicting prostate
- predicting
- metastasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1617723.0A GB201617723D0 (en) | 2016-10-19 | 2016-10-19 | Method for predicting prostate cancer metastasis |
PCT/EP2017/076786 WO2018073382A1 (en) | 2016-10-19 | 2017-10-19 | Method for predicting prostate cancer metastasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1617723.0A GB201617723D0 (en) | 2016-10-19 | 2016-10-19 | Method for predicting prostate cancer metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201617723D0 true GB201617723D0 (en) | 2016-11-30 |
Family
ID=57680827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1617723.0A Ceased GB201617723D0 (en) | 2016-10-19 | 2016-10-19 | Method for predicting prostate cancer metastasis |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201617723D0 (en) |
WO (1) | WO2018073382A1 (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE199392T1 (en) | 1992-12-04 | 2001-03-15 | Medical Res Council | MULTIVALENT AND MULTI-SPECIFIC BINDING PROTEINS, THEIR PRODUCTION AND USE |
US5427663A (en) | 1993-06-08 | 1995-06-27 | British Technology Group Usa Inc. | Microlithographic array for macromolecule and cell fractionation |
US6692952B1 (en) | 1999-11-10 | 2004-02-17 | Massachusetts Institute Of Technology | Cell analysis and sorting apparatus for manipulation of cells |
US8895298B2 (en) | 2002-09-27 | 2014-11-25 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
ATE463292T1 (en) | 2002-10-23 | 2010-04-15 | Univ Princeton | METHOD FOR CONTINUOUS PARTICLE SEPARATION USING OBSTACLE ARRAYS ASYMMETRICALLY ALIGNED IN FIELDS |
CA2529285A1 (en) | 2003-06-13 | 2004-12-29 | The General Hospital Corporation | Microfluidic systems for size based removal of red blood cells and platelets from blood |
ES2695101T3 (en) * | 2011-12-30 | 2019-01-02 | Ventana Med Syst Inc | Automated analysis of circulating tumor cells |
WO2014120265A1 (en) * | 2013-02-02 | 2014-08-07 | Duke University | Method of isolating circulating tumor cells |
US9631179B2 (en) | 2013-03-15 | 2017-04-25 | Angle North America, Inc. | Methods for segregating particles using an apparatus with a size-discriminating separation element having an elongate leading edge |
US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
WO2016049658A1 (en) * | 2014-09-26 | 2016-03-31 | The Regents Of The University Of California | Method of assessing disease condition of cancer |
-
2016
- 2016-10-19 GB GBGB1617723.0A patent/GB201617723D0/en not_active Ceased
-
2017
- 2017-10-19 WO PCT/EP2017/076786 patent/WO2018073382A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2018073382A1 (en) | 2018-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL304252A (en) | Method for treating cancer | |
IL289947A (en) | Method for treating cancer | |
HK1247276A1 (en) | Biomarkers for pancreatic cancer | |
GB201500584D0 (en) | Cancer biomarkers | |
IL251141A0 (en) | A method of predicting risk of recurrence of cancer | |
SG11201701875YA (en) | Methods for detecting ovarian cancer | |
PL3201635T3 (en) | Method for predicting cancer progression by nanomechanical profiling | |
EP3410118A4 (en) | Prostate carcinoma determination method | |
HK1250257A1 (en) | Biomarker combinations for prostate disease | |
GB201517028D0 (en) | Novel biomarkers for pancreatic cancer | |
GB201418242D0 (en) | Genetic biomarkers and method for evaluating cancers | |
EP3093343A4 (en) | Method for assessing lymph node metastatic potential of endometrial cancer | |
HK1249134A1 (en) | Biomarkers for colorectal cancer related diseases | |
IL259661A (en) | Biomarkers for treating cancer with apilimod | |
IL257514A (en) | Cancer detection method | |
IL265537A (en) | Methods for treating ovarian cancer | |
EP3332037A4 (en) | Methods for predicting prostate cancer relapse | |
GB201617723D0 (en) | Method for predicting prostate cancer metastasis | |
GB201617722D0 (en) | Method for determining prognosis of cancer | |
EP3470528A4 (en) | Method for predicting effect of pharmacotherapy on cancer | |
SG11201608328RA (en) | Method for predicting response to therapy for cancer | |
EP3082087C0 (en) | Mobile payment method | |
GB201506666D0 (en) | Biomarkers for prostate cancer | |
GB201600329D0 (en) | Biomarker panel for prostate cancer | |
GB201703640D0 (en) | Prostate cancer biomarkers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |